Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells
N. Rahimi et al., Receptor chimeras indicate that the vascular endothelial growth factor receptor-1 (VEGFR-1) modulates mitogenic activity of VEGFR-2 in endothelial cells, J BIOL CHEM, 275(22), 2000, pp. 16986-16992
Vascular endothelial growth factor (VEGF) provokes angiogenesis in vivo and
stimulates growth and differentiation of endothelial cells in vitro. Altho
ugh VEGF receptor-1 (VEGFR-1) and VEGFR-2 are known to be high affinity rec
eptors for VEGF, it is not clear which of the VEGFRs are responsible for th
e transmission of the diverse biological responses of VEGF. For this purpos
e we have constructed a chimeric receptor for VEGFR-1 (CTR) and VEGFR-2 (CK
R) in which the extracellular domain of each receptor was replaced with the
extracellular domain of human colony-stimulating factor-1 receptor (CSF-1R
), and these receptors were expressed in pig aortic endothelial (PAE) cells
. We show that CHR individually expressed in PAE cells is readily tyrosine-
phosphorylated in vivo, autophosphorylated in vitro, and stimulates cell pr
oliferation in a CSF-1-dependent manner. In contrast, CTR individually expr
essed in PAE cells showed no significant in vivo, in vitro tyrosine phospho
rylation and cell growth in response to CSF-1 stimulation. The kinase activ
ity of CKR was essential for its biological activity, since mutation of lys
ine 866 to arginine abolished its in vivo, in vitro tyrosine phosphorylatio
n and mitogenic signals. Remarkably, activation of CTR repressed CKR-mediat
ed mitogen-activate protein kinase activation and cell proliferation. Simil
ar effects were observed for VEGFR-2 co-expressed with VEGFR-1. Collectivel
y, these findings demonstrate that VEGFR-8 activation plays a positive role
in angiogenesis by promoting endothelial cell proliferation In contrast, a
ctivation of VEGFR-1 plays a stationary role in angiogenesis by antagonizin
g VEGFR-2 responses.